Epidemiology of non-AD dementias
暂无分享,去创建一个
[1] A. Hofman,et al. Diet and risk of dementia: Does fat matter? , 2002, Neurology.
[2] A. Hofman,et al. The prevalence of vascular dementia in europe: Facts and fragments from 1980–1990 studies , 1991, Annals of neurology.
[3] Hitoshi Takahashi,et al. Clinical features of familial diffuse Lewy body disease. , 1997, European neurology.
[4] P. Mcgeer,et al. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.
[5] E. Barrett-Connor,et al. Serum lipoprotein levels, statin use, and cognitive function in older women. , 2002, Archives of neurology.
[6] P. O'Brien,et al. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. , 1997, American journal of epidemiology.
[7] A. Goate,et al. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease , 1996, The Lancet.
[8] M. Viitanen,et al. CADASIL: a Common Form of Hereditary Arteriopathy Causing Brain Infarcts and Dementia , 2002, Brain pathology.
[9] C. K. Liu,et al. Incidence and subtypes of dementia in southern Taiwan Impact of socio‐demographic factors , 1998, Neurology.
[10] M. Bullido,et al. APOE genotype in cerebrovascular disease and vascular dementia , 2002, Journal of the Neurological Sciences.
[11] P. Amouyel,et al. The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment , 1996, Neuroscience Letters.
[12] M. Hutton,et al. The molecular genetics of the tauopathies , 2000, Experimental Gerontology.
[13] J. Littleton,et al. Inhibition of Platelet Aggregation by Ethanol in Vitro Shows Specificity for Aggregating Agent Used and Is Influenced by Platelet Lipid Composition , 1982, Thrombosis and Haemostasis.
[14] M. Hennerici,et al. Are gait disturbances and white matter degeneration early indicators of vascular dementia? , 1994, Dementia.
[15] P. Winocour,et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. , 1991, Atherosclerosis.
[16] J. Morris,et al. Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutations , 1999, Neuroscience Letters.
[17] D. Geschwind,et al. The apolipoprotein E ε4 allele is not a significant risk factor for frontotemporal dementia , 1998 .
[18] M. Greicius,et al. Presenile dementia syndromes: an update on taxonomy and diagnosis , 2002, Journal of neurology, neurosurgery, and psychiatry.
[19] A. Hofman,et al. Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.
[20] E. Rimm,et al. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits? , 1996, BMJ.
[21] M. Ferrari,et al. Subcortical lacunar lesions: an MR imaging finding in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. , 2002, Radiology.
[22] H. Markus,et al. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. , 1995, Stroke.
[23] P. Schnohr,et al. Mortality associated with moderate intakes of wine, beer, or spirits , 1995, BMJ.
[24] R. Mayeux,et al. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. , 2001, American journal of epidemiology.
[25] P. Gorelick,et al. Risk Factors for Dementia Associated With Multiple Cerebral Infarcts: A Case-Control Analysis in Predominantly African-American Hospital-Based Patients , 1993 .
[26] G. Boers,et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. , 1985, The New England journal of medicine.
[27] S. Levine,et al. Quantitative MRI findings and cognitive impairment among community dwelling elderly subjects , 2002, Journal of neurology, neurosurgery, and psychiatry.
[28] S. Li,et al. A three‐year follow‐up study of age‐related dementia in an urban area of Beijing , 1991, Acta psychiatrica Scandinavica.
[29] Matthijs Oudkerk,et al. Incidence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study , 2003, Stroke.
[30] B. Lernfelt,et al. 15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.
[31] M. Viitanen,et al. Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E epsilon4. , 2001, Neuroreport.
[32] D. Neary,et al. Apolipoprotein E ϵ4 Allele Has No Effect on Age at Onset or Duration of Disease in Cases of Frontotemporal Dementia with Pick- or Microvacuolar-Type Histology , 2000, Experimental Neurology.
[33] A Hofman,et al. Gender differences in the incidence of AD and vascular dementia , 1999, Neurology.
[34] S. Tsuji,et al. Autosomal dominant diffuse Lewy body disease , 1998, Acta Neuropathologica.
[35] A. Hofman,et al. Education and the incidence of dementia in a large population-based study: The Rotterdam Study , 1999, Neurology.
[36] D. Siscovick,et al. Alcohol Consumption and Subclinical Findings on Magnetic Resonance Imaging of the Brain in Older Adults: The Cardiovascular Health Study , 2001, Stroke.
[37] I. Skoog,et al. Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. , 1998, Archives of neurology.
[38] N. Bornstein,et al. APOE-ε4 in Patients with Alzheimer Disease and Vascular Dementia , 1996 .
[39] M. Rossor,et al. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases , 1999, Journal of neurology, neurosurgery, and psychiatry.
[40] T. Bird,et al. Familial dementia with lewy bodies: a clinical and neuropathological study of 2 families. , 2002, Archives of neurology.
[41] S. Berg,et al. The influence of white matter lesions on neuropsychological functioning in demented and non‐demented 85‐year‐olds , 1996, Acta neurologica Scandinavica.
[42] E. Perry,et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. , 1994, The American journal of pathology.
[43] L. White,et al. A longitudinal study of drinking and cognitive performance in elderly Japanese American men: the Honolulu-Asia Aging Study. , 2000, American journal of public health.
[44] L. Kuller. Prevention of cardiovascular disease and the future of cardiovascular disease epidemiology. , 2001, International journal of epidemiology.
[45] J. Klein,et al. Stimulatory and inhibitory effects of ethanol on hippocampal acetylcholine release , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.
[46] S. Adkins,et al. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. , 1993, American journal of human genetics.
[47] Albert Hofman,et al. Alcohol consumption and risk of dementia: the Rotterdam Study , 2002, The Lancet.
[48] A. Hofman,et al. Blood Pressure and Risk of Dementia: Results from the Rotterdam Study and the Gothenburg H-70 Study , 2000, Dementia and Geriatric Cognitive Disorders.
[49] E. Braak,et al. Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease , 1998, Brain Research.
[50] R. Mayeux,et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke. , 1999, JAMA.
[51] L. Launer,et al. Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study , 2002, Neurology.
[52] T. Dantoine,et al. Paraoxonase as a Risk Marker for Cardiovascular Disease: Facts and Hypotheses , 1998, Clinical chemistry and laboratory medicine.
[53] M. Sjögren,et al. The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population based sample of 85 year olds , 2003, Journal of neurology, neurosurgery, and psychiatry.
[54] M. Blatter,et al. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. , 1993, European journal of biochemistry.
[55] J. Lindsay,et al. The Canadian Study of Health and Aging: risk factors for vascular dementia. , 1997, Stroke.
[56] P. de Knijff,et al. Apolipoprotein E gene and sporadic frontal lobe dementia , 1997, Neurology.
[57] J R Hodges,et al. The prevalence of frontotemporal dementia , 2002, Neurology.
[58] J. Buring,et al. Light-to-moderate alcohol consumption and the risk of stroke among U.S. male physicians. , 1999, The New England journal of medicine.
[59] J. Lalouel,et al. Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins. , 1997, Journal of lipid research.
[60] B. Dubois,et al. Association between the extended tau haplotype and frontotemporal dementia. , 2002, Archives of neurology.
[61] C. Katona,et al. Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies , 2000, International journal of geriatric psychiatry.
[62] W. Jagust,et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.
[63] S. Xiao,et al. A preliminary analysis of incidence of dementia in Shanghai, China , 1998, Psychiatry and clinical neurosciences.
[64] Monique M. B. Breteler,et al. Incidence of dementia: does gender make a difference? , 2001, Neurobiology of Aging.
[65] J. Jolles,et al. Comparison of seven sets of criteria used for the diagnosis of vascular dementia. , 1996, Neuroepidemiology.
[66] P. Scheltens,et al. Familial aggregation in frontotemporal dementia , 1998, Neurology.
[67] G. Román. Diagnosis of vascular dementia and Alzheimer's disease. , 2001, International journal of clinical practice. Supplement.
[68] E. Feskens,et al. Smoking, drinking, and thinking. The Zutphen Elderly Study. , 1996, American journal of epidemiology.
[69] G. Zuliani,et al. Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia , 2001, Acta neurologica Scandinavica.
[70] T M Hayes,et al. Associations of alcohol consumption with plasma high density lipoprotein cholesterol and its major subfractions: the Caerphilly and Speedwell Collaborative Heart Disease Studies. , 1988, Journal of epidemiology and community health.
[71] D. Knopman,et al. Survival study of vascular dementia in Rochester, Minnesota. , 2003, Archives of neurology.
[72] M. Breteler,et al. Vascular risk factors for Alzheimer’s disease: An epidemiologic perspective , 2000, Neurobiology of Aging.
[73] M. Kokai,et al. Familial dementia with Lewy bodies (DLB). , 1999, Clinical neuropathology.
[74] J. Berliner,et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. , 1995, The Journal of clinical investigation.
[75] Skidgel Ra,et al. The angiotensin I-converting enzyme. , 1977 .
[76] Curt D. Furberg,et al. Incidence, Manifestations, and Predictors of Brain Infarcts Defined by Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study , 2002, Stroke.
[77] Oscar L. Lopez,et al. Risk Factors for Dementia in the Cardiovascular Health Cognition Study , 2003, Neuroepidemiology.
[78] G. Schellenberg,et al. Apolipoprotein E genotype and Alzheimer's disease , 1993, The Lancet.
[79] Y. Yamori,et al. Prevalence of Alzheimer's disease, vascular dementia and dementia with Lewy bodies in a Japanese population , 2001, Psychiatry and clinical neurosciences.
[80] D. Tomassoni,et al. Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension Analysis of published clinical data , 2002, Journal of the Neurological Sciences.
[81] L. Launer,et al. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.
[82] A. Hofman,et al. Non-insulin-dependent Diabetes Mellitus (niddm) Association of Diabetes Mellitus and Dementia: the Rotterdam Study , 2022 .
[83] M. Freedman,et al. Frontotemporal lobar degeneration , 1998, Neurology.
[84] K. Asplund,et al. Diabetes as a risk factor for stroke. A population perspective , 1995, Diabetologia.
[85] Diederick E Grobbee,et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study , 1995, BMJ.
[86] J. Lindsay,et al. Vascular dementia : incidence and risk factors in the Canadian study of health and aging. , 2000, Stroke.
[87] R. Havlik,et al. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. , 1995, JAMA.
[88] N. Bornstein,et al. ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. , 1998, Stroke.
[89] A Hofman,et al. Diabetes mellitus and the risk of dementia , 1999, Neurology.
[90] M. Etminan,et al. The Role of Lipid‐Lowering Drugs in Cognitive Function: A Meta‐Analysis of Observational Studies , 2003, Pharmacotherapy.
[91] I. McKeith. Dementia with Lewy bodies , 2002, British Journal of Psychiatry.
[92] R. D'Agostino,et al. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. , 1993, American journal of epidemiology.
[93] A. Hofman,et al. Antihypertensive drugs and incidence of dementia: the Rotterdam Study , 2001, Neurobiology of Aging.
[94] S. Rosso. Frontotemporal Dementia in the Netherlands , 2003 .
[95] L M Schuman,et al. A case-control study of dementia of the Alzheimer type. , 1985, American journal of epidemiology.
[96] L R White,et al. Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study. , 1990, Journal of clinical epidemiology.
[97] R. Roos,et al. Hereditary cerebral hemorrhage with amyloidosis--Dutch type (HCHWA-D): a review of the variety in phenotypic expression. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[98] Charles DeCarli,et al. APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD , 1999, Neurology.
[99] R. Katzman.,et al. Education and the prevalence of dementia and Alzheimer's disease , 1993, Neurology.
[100] J. Mohr,et al. The natural history of CADASIL: a pooled analysis of previously published cases. , 1999, Stroke.
[101] H. Arai,et al. Presenilin-1 Polymorphism in Alzheimer's Disease and Vascular Dementia , 1997, Experimental Neurology.
[102] M. L. Fravolini,et al. Angiotensin converting enzyme deletion allele in different kinds of dementia disorders , 1999, Neuroscience Letters.
[103] B. Winblad,et al. Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. , 1999, Journal of clinical epidemiology.
[104] D. Commenges,et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. , 1997, Revue neurologique.
[105] R Doll,et al. Smoking and dementia in male British doctors: prospective study , 2000, BMJ : British Medical Journal.
[106] W. Frishman. Are antihypertensive agents protective against dementia? A review of clinical and preclinical data. , 2002, Heart disease.
[107] A. Singleton,et al. Clinical and Neuropathological Correlates of Apolipoprotein E Genotype in Dementia with Lewy Bodies , 2002, Dementia and Geriatric Cognitive Disorders.
[108] H S Markus,et al. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL , 2001, Neurology.
[109] M. Idelson,et al. The C677T Mutation in the Methylenetetrahydrofolate Reductase (MTHFR) Gene and Vascular Dementia , 2000, Journal of the American Geriatrics Society.
[110] A. Hofman,et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study , 1997, The Lancet.
[111] A. Hofman,et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study , 1998, The Lancet.
[112] L. Kuller,et al. Prospective study of alcohol consumption and risk of dementia in older adults. , 2003, JAMA.
[113] B. Winblad,et al. Very Old Women at Highest Risk of Dementia and Alzheimer's Disease , 1997, Neurology.
[114] Hsuan-Cheng Huang,et al. Apolipoprotein E polymorphism in various dementias in Taiwan Chinese population , 2002, Journal of Neural Transmission.
[115] J. Biller,et al. Cerebrovascular disorders in patients with diabetes mellitus. , 1996, Journal of diabetes and its complications.
[116] B. Winblad,et al. Low blood pressure and dementia in elderly people: the Kungsholmen project , 1996, BMJ.
[117] M. Brown,et al. How LDL receptors influence cholesterol and atherosclerosis. , 1984, Scientific American.
[118] J Marshall,et al. Cerebral blood flow in dementia. , 1975, Archives of neurology.
[119] M. Cogné,et al. Paraoxonase 1 192/55 Gene Polymorphisms in Alzheimer's Disease , 2002, Annals of the New York Academy of Sciences.
[120] T. Wetterling,et al. The ICD-10 criteria for vascular dementia. , 1994, Dementia.
[121] P. Frosst,et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. , 1996, American journal of human genetics.
[122] H. Bickel,et al. Incidence and relative risk of dementia in an urban elderly population: findings of a prospective field study , 1994, Psychological Medicine.
[123] C. V. van Duijn,et al. Apolipoprotein E4 in the temporal variant of frontotemporal dementia , 2002, Journal of neurology, neurosurgery, and psychiatry.
[124] G. Lenzi,et al. Serum lipoprotein pattern variations in dementia and ischemic stroke , 1990, Acta neurologica Scandinavica.
[125] A. Hofman,et al. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. , 1997, JAMA.
[126] T. Truelsen,et al. Amount and type of alcohol and risk of dementia , 2002, Neurology.
[127] G. C. Román,et al. Vascular dementia , 1993, Neurology.
[128] E. Arbustini,et al. Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. , 1995, British heart journal.
[129] C. Mamotte,et al. Apolipoprotein ∈4 homozygosity in young men with coronary heart disease , 1992, The Lancet.
[130] J. Kesslak. Can estrogen play a significant role in the prevention of Alzheimer's disease? , 2002, Journal of neural transmission. Supplementum.
[131] E. Perry,et al. Multiple substrates of late-onset dementia: implications for brain protection. , 2001, Novartis Foundation symposium.
[132] K. Kosaka,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.
[133] R. Mayeux,et al. Clinical determinants of dememtia related to stroke , 1993, Annals of neurology.
[134] A. Hofman,et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.
[135] K. Blennow,et al. Cerebrospinal Fluid Beta-Amyloid 42 Is Reduced before the Onset of Sporadic Dementia: A Population-Based Study in 85-Year-Olds , 2003, Dementia and Geriatric Cognitive Disorders.
[136] Janice L Holton,et al. Sporadic and Familial Cerebral Amyloid Angiopathies , 2002, Brain pathology.
[137] C. Duijn,et al. Role of APOE in dementia: A critical reappraisal. , 1998 .
[138] F. Boller,et al. Apolipoprotein E ε4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease , 2002, Journal of the Neurological Sciences.
[139] L. Donini,et al. DNA Polymorphisms of Apolipoprotein B and Angiotensin I-Converting Enzyme Genes and Relationships with Lipid Levels in Italian Patients with Vascular Dementia or Alzheimer’s Disease , 1998, Dementia and Geriatric Cognitive Disorders.
[140] R. Zec,et al. The Effects of Estrogen Replacement Therapy on Neuropsychological Functioning in Postmenopausal Women With and Without Dementia: A Critical and Theoretical Review , 2002, Neuropsychology Review.
[141] R. Mayeux,et al. Dementia after stroke , 1992, Neurology.
[142] K. Svärdsudd,et al. Age-related changes in blood pressure. , 1986, Hypertension.
[143] N. Tachibana,et al. Increased prevalence of vascular dementia in Japan , 2001, Neurology.
[144] R. Havlik,et al. Characterization of risk factors for vascular dementia , 1999, Neurology.
[145] T. Wetterling,et al. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). , 1996, Stroke.
[146] K. Nakashima,et al. Estrogen Receptor Gene Polymorphisms in Patients with Alzheimer’s Disease, Vascular Dementia and Alcohol-Associated Dementia , 2000, Dementia and Geriatric Cognitive Disorders.
[147] J. Thornby,et al. Education and occupation as risk factors for dementias of the Alzheimer and ischemic vascular types. , 1995, Dementia.
[148] J. V. van Swieten,et al. New developments in frontotemporal dementia and parkinsonism linked to chromosome 17 , 2002, Current opinion in neurology.
[149] A. McCall. The Impact of Diabetes on the CNS , 1992, Diabetes.
[150] L. Launer. Demonstrating the case that AD is a vascular disease: epidemiologic evidence , 2002, Ageing Research Reviews.
[151] C. Loeb,et al. Dementia Associated With Lacunar Infarction , 1992, Stroke.
[152] K. Blennow,et al. Prevalence and Incidence of Clinically Diagnosed Memory Impairments in a Geographically Defined General Population in Sweden , 1999, Neuroepidemiology.
[153] G. Livingston,et al. Islington study of dementia subtypes in the community. , 2002, The British journal of psychiatry : the journal of mental science.
[154] Broustet Jp. Wine and health , 1999 .
[155] K. Jellinger,et al. The pathology of ischemic-vascular dementia An update , 2002, Journal of the Neurological Sciences.